NCT05728528View on ClinicalTrials.gov

Impact of Moderate Intensity Physical Activities on PK-guided EHL FVIII Concentrates Prophylaxis Severe HA Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Hemophilia
Interventions
DRUG

combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis

combination between moderate to vigorous-intensity physical activities and pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis

DRUG

pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis alone

pharmacokinetic-guided extended half-life FVIII concentrates prophylaxis alone

Trial Locations (1)

10330

King Chulalongkorn Memorial Hospital, Bangkok

All Listed Sponsors
lead

Chulalongkorn University

OTHER